ADB-106

N/A

Report date: 2026/02/26 20:00:22

Base Information

Drug NameADB-106
Drug Alias NameADB-106ADB106
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCarbonic anhydrase-related protein gene transference
TargetsCarbonic anhydrase-related protein
Therapy Area/IndicationsEye Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAdolore Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAdolore Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsEye Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A